ASSEMBLY BIOSCIENCES, INC.
Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.
ASMB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US0453962070
- LEI:
- Country:
- United States of America
- Address:
- TWO TOWER PLACE, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.assemblybio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Assembly Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to treat serious viral diseases. Leveraging deep expertise in virology, the company discovers and advances novel, small-molecule antiviral candidates. Its pipeline targets challenging viral infections such as herpes, hepatitis B (HBV), and hepatitis delta (HDV). Assembly Bio is committed to changing the treatment paradigm for patients and collaborates with strategic partners to accelerate the development of next-generation therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ASSEMBLY BIOSCIENCES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ASSEMBLY BIOSCIENCES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ASSEMBLY BIOSCIENCES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
